998 resultados para Milk commissions, Medical
Resumo:
Receipt from Mrs. Bunting for milk and cream, Feb. 8, 1888.
Resumo:
Receipt from Mrs. Bunting, St. Catharines for milk and cream, Feb. 15, 1888.
Resumo:
Receipt from Mrs. Bunting for milk and cream, Feb. 29, 1888.
Resumo:
Receipt from Mrs. Bunting for milk and cream, March 7, 1888.
Resumo:
Receipt from Mrs. Bunting for milk, March 14, 1888.
Resumo:
Receipt from Mrs. Bunting for milk, March 28, 1888.
Resumo:
Receipt from Mrs. Bunting for milk, Apr. 12, 1888.
Resumo:
List of officers and dates of commissions and appointments in the 4th Regiment of the Lincoln Militia including the troop of cavalry in the 4th Lincoln Militia (2 pages, handwritten), June 18, 1838.
Resumo:
The Standards Committee of the Veterinary Medical Libraries Section was appointed in May 2000 and charged to create standards for the ideal academic veterinary medical library, written from the perspective of veterinary medical librarians. The resulting Standards for the Academic Veterinary Medical Library were approved by members of the Veterinary Medical Libraries Section during MLA ’03 in San Diego, California. The standards were approved by Section Council in April 2005 and received final approval from the Board of Directors of the Medical Library Association during MLA ’04 in Washington, DC.
Resumo:
We consider entry-level medical markets for physicians in the United Kingdom. These markets experienced failures which led to the adoption of centralized market mechanisms in the 1960's. However, different regions introduced different centralized mechanisms. We advise physicians who do not have detailed information about the rank-order lists submitted by the other participants. We demonstrate that in each of these markets in a low information environment it is not beneficial to reverse the true ranking of any two acceptable hospital positions. We further show that (i) in the Edinburgh 1967 market, ranking unacceptable matches as acceptable is not profitable for any participant and (ii) in any other British entry-level medical market, it is possible that only strategies which rank unacceptable positions as acceptable are optimal for a physician.
Resumo:
UANL
Resumo:
UANL
Resumo:
L’accès aux traitements de base est un enjeu crucial pour la santé, la pauvreté et le développement. La responsabilité en matière d’accès est alors une question essentielle. Le huitième Objectif du Millénaire pour le Développement postule qu’en coopération avec les firmes pharmaceutiques, l’accès aux traitements essentiels doit être assuré. Les principales parties prenantes qui doivent engager leur responsabilité pour l’accès aux médicaments sont (1) l’industrie pharmaceutique, (2) les gouvernements, (3) la société au sens large, et (4) les individus (qu’ils soient ou non malades). Quatre approches permettent d’appréhender la responsabilité: (a) l’approche déontologique; (b) l’utilitarisme; (c) l’égalitarisme; (b) l’approche basée sur les droits de l’homme. Ces quatre arguments peuvent être utilisés pour assigner une responsabilité aux gouvernements dans l’accès aux médicaments. Le papier conclut qu’il est parfois difficile de distinguer entre ces quatre approches et qu’un « glissement-d’échelle » de la responsabilité est une voie utile pour appréhender les rôles des quatre principales parties prenantes dans l’accès aux médicaments, dépendant du pays ou de la région et de son environnement interne.